Header Logo

Connection

MICHAEL JOHNSON to Cisplatin

Back to Details
This is a "connection" page, showing publications MICHAEL JOHNSON has written about Cisplatin.
MICHAEL JOHNSON
Connection Strength
0.028
Cisplatin
  1. CMF-regimen preferred as first-course chemotherapy for older and sicker women with breast cancer: Findings from a SEER-Medicare-based population study. Am J Clin Oncol. 2015 Apr; 38(2):165-73.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.